Dr Yong Wei Peng


Associate Director (Research) and Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS)

 

Adjunct Research Fellow, Cancer Science Institute of Singapore, National University of Singapore

 

Dr Yong Wei Peng obtained his medical degree and postgraduate training in University of Aberdeen, Scotland. After completing an oncology fellowship at the National University Hospital, he was awarded the A*star international clinical pharmacology fellowship at the University of Chicago. Upon his return to Singapore, he was awarded a three-year Investigatorship Award under the Clinician Scientist Award to further his research into personalized therapy. Dr Yong leads the therapeutic arm (NUH module) of the Singapore Gastric Cancer Consortium. The consortium received the prestigious five-year Translational Clinical Research grant in 2007. He is also the Chairman of the National Healthcare Group Domain-Specific Ethics Review Board. His clinical interest is in gastrointestinal cancers and his research interests are pharmacogenetics and epigenetics in cancer.

 

Education and Fellowships

MB ChB (University of Aberdeen), MRCP (UK), Clinical Pharmacology Fellowship (University of Chicago)

 

Specialty Interests

  • Gastrointestinal Cancer
  • Liver & Pancreatic Cancer
  • Phase I Clinical Trials

 

Awards and Honours

  • TCR gastric flagship program grant
  • NMRC- Center Grant
  • NMRC-BMRC Clinician Scientist Investigator award
  • A*star International Fellowship

 

Professional Memberships

  • Member, American Society of Clinical Oncology

 

Updated as of 24 March 2015